Skip to main content
PhoenixBio Co.,Ltd. logo

PhoenixBio Co.,Ltd. — Investor Relations & Filings

Ticker · 6190 ISIN · JP3803010002 T Professional, scientific and technical activities
Open in API
Filings indexed 63 across all filing types
Latest filing 2024-06-27 Governance Information
Country JP Japan
Listing T 6190

About PhoenixBio Co.,Ltd.

https://phoenixbio.co.jp/

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Recent filings

Filing Released Lang Actions
内部統制報告書－第23期(2023/04/01－2024/03/31)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the header and within the table structure. It references the legal basis as "金融商品取引法第24条の４の４第１項" (Financial Instruments and Exchange Act Article 24-4-4, Paragraph 1), which mandates the filing of an Internal Control Report by listed companies in Japan. The content discusses the framework, scope, criteria, and results of the assessment of internal controls over financial reporting as of the fiscal year-end (March 31, 2024). This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although in this specific context, it is the Japanese equivalent of the Sarbanes-Oxley Section 404 report on internal controls over financial reporting. Given the provided options, 'AR' (Audit Report / Information) is the closest fit for a formal report detailing internal control assessment results, distinct from the full Annual Report (10-K) or a simple Earnings Release (ER).
2024-06-27 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document text contains Japanese regulatory headers, specifically mentioning "有価証券報告書" (Yūka Shōken Hōkokusho), which translates to 'Securities Report' or 'Annual Securities Report'. It also references the '金融商品取引法' (Financial Instruments and Exchange Act) and lists a submission date (2024年６月27日) and a fiscal period (第23期, ending March 31, 2024). The content confirms the accuracy of the Securities Report for the period. In the context of US SEC filings, the closest equivalent to a comprehensive annual securities report is the 10-K. Given the context of a comprehensive annual filing confirmation, 10-K is the most appropriate classification, even though the source document is Japanese (which often uses a similar structure for annual filings). The document is a confirmation/attestation related to the annual filing, but the core subject matter is the Annual Report itself. FY 2024
2024-06-27 Japanese
有価証券報告書－第23期(2023/04/01－2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard annual securities report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending March 31, 2024. This corresponds to the 10-K filing category in the provided schema. FY 2024
2024-06-27 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the title "第３四半期報告書" (Third Quarter Report) and specifies the period covered: "第23期第３四半期（自 2023年10月１日 至 2023年12月31日）". It also references compliance with the Financial Instruments and Exchange Act ("金融商品取引法"). This structure and content strongly indicate a comprehensive financial report for an interim period shorter than a year, which corresponds to the Interim / Quarterly Report definition. The code for this is IR.
2024-02-14 Japanese
四半期報告書－第23期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by PhoenixBio Co., Ltd. with the Chugoku Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the third quarter of the fiscal year ending March 31, 2024. As it provides comprehensive financial data for an interim period (Q3), it is classified as an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
臨時報告書
Regulatory Filings Classification · 95% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Director of the Kanto Local Finance Bureau. The content explicitly states that it is being filed based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, due to an event significantly impacting the company's financial condition, operating results, and cash flow. The specific event detailed is the recognition of foreign exchange gains due to currency fluctuations, quantified for the second quarter cumulative period of the fiscal year ending March 2024. This structure—a mandatory, timely disclosure of a significant, non-periodic financial event—aligns best with the general category for regulatory filings that aren't standard periodic reports (like 10-K or IR). Since there is no specific code for a general 'Extraordinary Report' (which often maps to an 8-K equivalent in the US context), and it is not a dividend, management change, or director dealing, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a formal submission mandated by financial regulations for material events.
2023-11-20 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.